[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 48, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pauline  Dufresne", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 16.91, "open": 16.8, "dayLow": 16.24, "dayHigh": 17.16, "regularMarketPreviousClose": 16.91, "regularMarketOpen": 16.8, "regularMarketDayLow": 16.24, "regularMarketDayHigh": 17.16, "payoutRatio": 0.0, "trailingPE": 3.1401868, "forwardPE": -5.6737585, "volume": 288773, "regularMarketVolume": 288773, "averageVolume": 606533, "averageVolume10days": 424890, "averageDailyVolume10Day": 424890, "bid": 16.74, "ask": 16.86, "bidSize": 1, "askSize": 1, "marketCap": 920336768, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 19.71, "allTimeHigh": 28.09, "allTimeLow": 7.8, "fiftyDayAverage": 17.3838, "twoHundredDayAverage": 13.857, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 632144768, "profitMargins": 0.0, "floatShares": 24214718, "sharesOutstanding": 54781950, "sharesShort": 8909119, "sharesShortPriorMonth": 8018780, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.1626, "heldPercentInsiders": 0.12164, "heldPercentInstitutions": 0.92265, "shortRatio": 15.68, "shortPercentOfFloat": 0.2539, "impliedSharesOutstanding": 54781950, "bookValue": 7.375, "priceToBook": 2.277966, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -121521000, "trailingEps": 5.35, "forwardEps": -2.961, "enterpriseToEbitda": -4.482, "52WeekChange": 0.37479675, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 16.8, "targetHighPrice": 48.0, "targetLowPrice": 11.0, "targetMeanPrice": 30.8, "targetMedianPrice": 30.5, "recommendationMean": 1.58333, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 290167008, "totalCashPerShare": 5.297, "ebitda": -141042000, "totalDebt": 1975000, "quickRatio": 13.799, "currentRatio": 14.142, "debtToEquity": 0.49, "returnOnAssets": -0.18591, "returnOnEquity": -0.26639998, "freeCashflow": -75155376, "operatingCashflow": -112980000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1769807404, "regularMarketTime": 1769806802, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.65050626, "regularMarketPrice": 16.8, "marketState": "CLOSED", "averageDailyVolume3Month": 606533, "fiftyTwoWeekLowChange": 8.999999, "fiftyTwoWeekLowChangePercent": 1.153846, "fiftyTwoWeekRange": "7.8 - 19.71", "fiftyTwoWeekHighChange": -2.9099998, "fiftyTwoWeekHighChangePercent": -0.1476408, "fiftyTwoWeekChangePercent": 37.479675, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 5.35, "epsForward": -2.961, "epsCurrentYear": -2.48, "priceEpsCurrentYear": -6.7741933, "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "fiftyDayAverageChange": -0.58380127, "fiftyDayAverageChangePercent": -0.033583064, "twoHundredDayAverageChange": 2.942999, "twoHundredDayAverageChangePercent": 0.21238355, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 16.8, "postMarketChange": 0.0, "regularMarketChange": -0.11000061, "regularMarketDayRange": "16.24 - 17.16", "fullExchangeName": "NasdaqGM", "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]